
- Telehealth Visits
- Provider Type: Physical Therapist

Hannah Baird, PT
Physical Therapy- Telehealth Visits
- Provider Type: Physical Therapist



Hannah Baird, PT
Physical Therapy- Telehealth Visits
- Provider Type: Physical Therapist
On this page
About me
Hannah Baird, PT, DPT, OCS, is a physical therapist and Health Sciences Assistant Clinical Professor at UCSF. She is a board-certified Orthopaedic Clinical Specialist with advanced training in the evaluation and treatment of musculoskeletal and movement-related conditions across the lifespan.
Baird earned her Doctor of Physical Therapy degree from Boston University and completed an Orthopaedic Physical Therapy Residency at UCSF. She treats pediatric through geriatric patients and post-operative individuals, with a focus on restoring function, optimizing movement, and supporting return to activities of daily living and higher-level physical performance.
In addition to her clinical work, she teaches in the UCSF/SFSU Doctor of Physical Therapy program and is dedicated to mentoring future clinicians through evidence-based practice.
Baird draws from her education, clinical experience, and background as a collegiate-level athlete to provide individualized, patient-centered care tailored to each patient’s goals.
Education & training
Academic title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%2293%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%2293%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.